APPAN Life Science
Technologies
Index™
TEAM:
Background in life
sciences (cancer) research (Ph.D.), life science market analysis, and
gene
expression analysis product management.
AIM:
Leverage unique
background for tracking and identifying opportunities for
investment in the life science and healthcare industry.
EXPERIENCE:
Strong foundation
in
life science research technologies (hands-on experience from graduate
school training) and as an industry analyst of life
science
markets and product manager for gene expression
analysis. Solid supply-side and market-demand
knowledge to
aide in identifying opportunities and challenges for the life science
technologies market.
POSITIONS
HELD:
- Global Product Manager: Gene
Expression Analysis (current)
- Industry Analyst: Drug
Discovery Technologies & Clinical
Diagnostics: Frost & Sullivan
TRAINING:
PRESS
PUBLISHED
MARKET STUDIES
- U.S. Cell-Based Assays (December 2007)
- U.S. Liquid Chromatography (June 2007)
- U.S. Protein Electrophoresis (December 2006)
- U.S. qRT-PCR (October 2006)
- U.S. Life Science Mass Spectrometry Market (July 2006)
Life
Science Technologies Index and LSTI are trademarks of
Appan Corporation.
Established September 16, 2009.